Development of the biopharmaceutical industry dominated by government: a case study from 'Pharmacy Valley' of China
by Jie Zhang, Ruxi Gao, Xiaojun Wu
International Journal of Healthcare Technology and Management (IJHTM), Vol. 11, No. 5, 2010

Abstract: We discuss a famous Hi-tech park for biopharmaceutical firms in Shanghai, China, whose formulation and growth are all sponsored by the government. After the background analysis of the biopharmaceutical industry, we focus on this park, known as Pharmacy Valley. With detailed analysis, we believe that although under the intensive support of government, the cooperation network among firms is still far from well set up, the financing channel is under-built, and the aggregation is in the primary stage. For all the firms in Pharmacy Valley, the gap is large on the scale of the industry, innovative capability and industrialisation level compared with multinationals.

Online publication date: Thu, 14-Oct-2010

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Healthcare Technology and Management (IJHTM):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com